These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7392571)

  • 1. Amyloid resistance in A/J mice. Studies with a transfer model.
    Wohlgethan JR; Cathcart ES
    Lab Invest; 1980 Jun; 42(6):663-7. PubMed ID: 7392571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidosis in (CBA/J X A/J)F2 mice: correlation of amyloid resistance and low mitogenic response to concanavalin A.
    Wohlgethan JR; Cathcart ES
    J Immunol; 1981 Sep; 127(3):1003-7. PubMed ID: 7264297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
    Gonnerman WA; Kandel R; Cathcart ES
    Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SJL/J mouse: a new model for spontaneous age-associated amyloidosis. I. Morphologic and immunochemical aspects.
    Scheinberg MA; Cathcart ES; Eastcott JW; Skinner M; Benson M; Shirahama T
    Lab Invest; 1976 Jul; 35(1):47-54. PubMed ID: 781403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of amyloid-enhancing factor.
    Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
    Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
    Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
    Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Casein-induced experimental amyloidosis. V. The response of lymphoid organs to T and B mitogens.
    Scheinberg MA; Bennett M; Cathcart ES
    Lab Invest; 1975 Jul; 33(1):96-101. PubMed ID: 49456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of amyloidosis by syngeneic spleen cells from normal donors.
    Axelrad M; Kisilevsky R; Beswetherick S
    Am J Pathol; 1975 Feb; 78(2):277-84. PubMed ID: 1115221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
    Snow AD; Kisilevsky R
    Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein-induced experimental amyloidosis. VI. A pathogenic role for b cells in the murine model.
    Scheinberg MA; Cathcart ES
    Immunology; 1976 Sep; 31(3):443-53. PubMed ID: 800407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inbred CE/J mouse strain as amyloid resistant.
    Sipe JD; Carreras I; Gonnerman WA; Cathcart ES; de Beer MC; de Beer FC
    Am J Pathol; 1993 Nov; 143(5):1480-5. PubMed ID: 7901995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein-induced experimental amyloidosis. IX. Alterations in marrow dependent function.
    Yonkosky D; Kumar V; Cathcart ES; Bennett M
    Immunology; 1978 Jul; 35(1):133-9. PubMed ID: 355124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental murine amyloidosis: a model system for studying amyloid formation.
    Baumal R; Wilson B; Pass E
    Can Med Assoc J; 1975 Sep; 113(6):512-6. PubMed ID: 1080430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amyloid transfer from a syngenous transplant of amyloid spleen in intact and amyloid mice].
    Sura VV; Osipova IN; Chebyshev AP; Serov VV; Gritsman AIu
    Biull Eksp Biol Med; 1978 Jun; 85(6):754-7. PubMed ID: 667351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of inflammatory cells in the pathogenesis of amyloidosis.
    Kisilevsky R; Axelrad M; Corbett W; Brunet S; Scott F
    Lab Invest; 1977 Dec; 37(6):544-53. PubMed ID: 599900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary structure of amyloid fibril protein AA in azocasein-induced amyloidosis of CBA/J mice.
    Dwulet FE; Benson MD
    J Lab Clin Med; 1987 Sep; 110(3):322-9. PubMed ID: 3611954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen.
    Shtrasburg S; Pras M; Gal R; Salai M; Livneh A
    J Lab Clin Med; 2001 Aug; 138(2):107-11. PubMed ID: 11477377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.